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Dr Wesley Moore (Los Angeles, Calif). Dr Huang, Dr Glov-
iczki, I’d like to congratulate you for presenting probably the
largest series of popliteal artery aneurysms reported in the litera-
ture. I have a couple of questions concerning technique, and then
I’d like to make a comment regarding an alternative surgical
approach. It’s my understanding that rather than doing a simple
ligation and bypass, which is the usual technique for saphenous
vein reconstruction, you actually opened the aneurysm and tookDr Peter Gloviczki. That’s correct that many patients had
endoaneurysmorrhaphy, but still more patients had the proximal
and distal ligation. We have used both. Most recently we prefer to
use endoaneurysmorrhaphy.
Dr Moore. That very nicely addresses one of my major
concerns, which is the possibility of a type II endoleak that’s been
reported due to the continued patency of the branches of the
popliteal aneurysm that continue to fill and pressurize the aneu-
rysm in spite of ligation and bypass.
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of patients that we have treated with an alternative technique,
which is the posterior approach to popliteal aneurysm. The aneu-
rysm sac is opened, the geniculate branches are ligated fromwithin,
and a short interposition prosthetic graft is used for reconstruction.
This has the advantage of not needing to harvest the saphenous
vein. Thus we save the vein and avoid wound complications related
to vein harvest. Our 2-year patency is about 98%, and, therefore,
we believe that is more than competitive with ligation and vein
bypass. I’d be interested to know the average length of stay of your
patients and also what the wound complications were for the
saphenous vein harvest site.
Dr Gloviczki. I think the technique that Dr Moore described
obviously deserves a lot of attention because you don’t have to
exclude the aneurysm and you don’t have to do endoaneurysmor-
rhaphy. It’s very similar to the operation that we do in the abdom-
inal aorta when we do an in situ repair.
The problem that we have seen is that many of our patients
were not really suitable for a popliteal-popliteal repair. When we
looked at the type of repair that we used in our patients, of the 368
patients that we operated, we found only 90 patients who had a
popliteal-popliteal bypass. Now, that may be because our bias that
we use the median approach and it is sometimes easier to go above
Hunter’s canal than below Hunter’s canal. And also because we
have consistently found, during the years, that saphenous vein did
definitely better than a PTFE graft.
In the paper that you reported, 2-year results were excellent,
but over 80% of your patients had an excellent two- to three-vessel
runoff. Well, our PTFE graft patients did very well with three-
vessel runoff. In fact, our PTFE graft patency at 2 years was 100%
when our patients had a three-vessel runoff. So I think PTFE is an
excellent choice, and it is a good graft material if you have two- or
three-vessel runoff. But when you have patients who have one-
vessel runoff or you have no vessel that goes down to the foot, we
found that in every category, at every time, the durability of PTFE
grafts were less.
Coming back to the issue of complications and the possibility
to do endoaneurysmorrhaphy from the medial approach, we use a
tight tourniquet that permits us a relatively short incision in the sac
of the aneurysm from a medial approach, evacuate the thrombus
from the sac, and approximate the walls of the aneurysm with 3-0
polypropylene sutures.
Dr Moore. Do you want to comment on the wound compli-
cations?
Dr Gloviczki. We had 28 minor wound complications.
Dr Kevin Martin (Cincinnati, Ohio). You’re stating that
open repair with saphenous vein is still the gold standard for
popliteal aneurysms. Yet your name was associated in the lay press
with a high-profile person down in Washington with an endovas-
cular repair with PTFE, which you have just said doesn’t seem to
work as well. So I was wondering if you would enlighten us on
when youwould abandon the gold standard on high-profile people
and go with an alternative approach.
Dr Gloviczki. We certainly have not abandoned the gold
standard. We discussed all the options with the high-profile pa-
tient, and it is the patient’s choice to make a decision knowing the
fact of what type of procedure he or she would like to choose.
There is no question in my mind, and there was no question in my
recommendations, that saphenous vein is a more durable alterna-
tive. There is, however, clearly an issue with the low-risk patients
and high-risk patients, and there is clearly an elevated risk in those
patients who have multiple previous myocardial infarctions to
undergo a surgical procedure versus a stent graft. So I think the
selection by the patient, who by the way had exceptionally good
three-vessel runoff, has proven so far very appropriate, and I am
very hopeful that it’s going to also give him exceptionally good
long-term results.Dr Thomas Lindsay (Toronto, Ontario, Canada). Many
patients with popliteal aneurysms have very ectatic, dilated, super-
ficial femoral arteries also. You have alluded to that, I think when
you noted that 90 of your patients were appropriate for a short
distance bypass, which relates to DrMoore’s point. Can you tell us
howmany of these people have a dilated, multisegment aneurysmal
ectatic SFA that you felt you needed to be dealt with at the same
time as the popliteal aneurysm?
And secondly, what about the biology of these saphenous vein
grafts? Your study suggests that these venous grafts don’t get the
same intimal hyperplasia and we don;t have the same difficulties
with secondary patency issues as we seem to have in the atheroscle-
rotic patients. I wonder if you could give us any insights into that
biology.
Dr Gloviczki. You bring up a very good point, and we had
some discussion yesterday of who are anatomically suitable for
a popliteal-popliteal reconstruction or who are good candidates for
a Viabahn stent graft. When we looked carefully and analyzed a
group of 119 patients if they were suitable candidates for stent
grafts because of their anatomy, we found that the proximal
dilation or frank aneurysmal changes were quite frequently
present. So for instance, only 45% of the 119 patients that we
imaged would have been candidates for a stent graft. And one of
the main reason was exactly an aneurysmal or diffusely dilated
proximal artery.
Coming back to the issue of secondary changes of the grafts, it
is clear to me that aneurysmal disease is different from occlusive
disease. Saphenous veins do better and more important, PTFE
grafts do excellent, because of the high flow and good runoff. So
that is, clearly, one of the reasons why we don’t see so many
secondary changes in these grafts because aneurysmal patients
frequently have much better runoff than patients with occlusive
disease.
Dr Patrick Geraghty (St. Louis, Mo). I am envious of your
20-year data collection; it represents a significant effort. I think you
have conclusively proven the point that acute presentation results
in themajority of limb loss. As you know, we are presenting a small,
mid-term series of the popliteal aneurysm endograft repairs. I think
your data help to define a potential subset of candidates for
endovascular intervention, in the sense that when I look at your
patients who received a PTFE graft in an elective setting, they had
somewhat reduced patency rates but no increased rate of limb loss.
I think that from a patient’s perspective, it would be attractive if
you could be offered an endovascular approach initially, with a
fallback option of saphenous vein or PTFE bypass. That approach
may result in quicker recovery times without changing limb loss
rates.
Dr Gloviczki. I think you bring up a good point, that we
don’t exactly know who are those asymptomatic patients with
popliteal artery aneurysm who need the repair. We found that
thrombus burden in a large aneurysm is a predictor of potential
problems. And we are going to have a second paper where we are
going to analyze the amount of thrombus present in popliteal
aneurysm and the subsequent development of embolization or
chronic symptoms.
But clearly, size matters in the decision to on operate
asymptomatic patients, since we found a difference in the size of
aneurysm of the three groups when you don’t count those
patients who have thrombosed aneurysm. The larger the aneu-
rysm, the higher the chance of complications. Interestingly, the
size of the thrombosed aneurysm was not different between the
three groups. But the size of the aneurysm in asymptomatic
patients is significantly less than in chronic symptom patients
or in acute symptom patients. And I think the thrombus bur-
den will be another one of the predictors that we can use in
the future to guide us on recommending popliteal aneurysm
repair.
